This Commure company profile covers the company's valuation, revenue, funding rounds, investors and history. Commure works in healthcare, with a focus on AI for health system operations. It was founded in 2017 and is headquartered in Mountain View, California, United States. Its latest valuation on record is About US$7 billion (reported) (2025). Every figure links to a public source, and anything the company hasn't disclosed is marked as such.
Revenue
| Metric | Value | As of | Source |
|---|---|---|---|
| Growth financing | US$200 million in growth financing from General Catalyst's Customer Value Fund | 2025 | Fierce Healthcare |
Funding history
| Date | Round | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| 2025 | Equity round | US$70M | About US$7B post-money (reported) | General Catalyst (lead); Sequoia Capital and others | MobiHealthNews |
| 2025 | Growth financing | US$200M | Not applicable | General Catalyst Customer Value Fund | Fierce Healthcare |
Commure timeline
Key dates from the sources on this page, oldest first. Metric snapshots are listed after the funding events.
- 2017 — Commure is founded in Mountain View by Incubated by General Catalyst; Tanay Tandon (CEO).
- 2025 — Growth financing: US$200M, valuing the company at Not applicable. Investors: General Catalyst Customer Value Fund.
- 2025 — Equity round: US$70M, valuing the company at About US$7B post-money (reported). Investors: General Catalyst (lead); Sequoia Capital and others.
- 2025 — Growth financing: US$200 million in growth financing from General Catalyst's Customer Value Fund.
Investors
Overview
Commure builds software and AI for hospitals, health systems and medical groups, focused on reducing administrative work for clinicians and staff. Its products include ambient AI that listens to doctor–patient conversations and drafts clinical notes, revenue cycle tools that automate billing and claims, patient engagement software, staff safety devices and remote monitoring. The company has said its aim is to give clinicians more time with patients by automating paperwork that has accumulated in US healthcare. Media reports in 2025 said a US$70 million round valued Commure at about US$7 billion, and it also received US$200 million in growth financing from General Catalyst.
Commure was incubated in 2017 by venture firm General Catalyst, led by partner Hemant Taneja, as a platform to modernise healthcare technology. In 2023 it merged with Athelas, a General Catalyst-backed company founded by Tanay Tandon that offered remote patient monitoring and AI-powered revenue cycle services. Tandon became CEO of the combined company. Commure is headquartered in Mountain View, California, and has acquired several healthcare technology companies to build its platform.
Products
- Ambient AI: an AI scribe that records and summarises visits into clinical notes inside the electronic health record.
- Revenue cycle management: AI-driven coding, billing, claims and collections, often delivered as a service.
- Patient engagement: scheduling, reminders and communication tools.
- Remote patient monitoring: devices and services from Athelas for monitoring patients at home.
- Staff safety: wearable panic buttons and location tracking for hospital workers, from its acquisition of Strongline.
Funding
Commure has been funded largely by General Catalyst, with other investors including Sequoia Capital. After the Athelas merger, General Catalyst invested US$70 million at a reported valuation of about US$6 billion for the combined company. In 2025, MobiHealthNews and Modern Healthcare reported a further US$70 million round with a post-money valuation of about US$7 billion, bringing total capital raised to about US$750 million. Separately, Commure received US$200 million in growth financing from General Catalyst's Customer Value Fund, which provides capital repaid from future revenue. Because reports differ on dates and details, we label the valuation as reported.
Business model
Commure sells software subscriptions and services to health systems and physician groups. Its revenue cycle business often charges a percentage of collections or fees per claim. Ambient AI is typically priced per clinician. Bundling multiple products lets Commure sell a platform rather than single tools, increasing contract sizes.
Competition
Commure competes with ambient AI companies such as Abridge, Ambience Healthcare, Microsoft's Nuance DAX and Suki; with revenue cycle companies such as R1 RCM, Waystar and Ensemble Health; and with electronic health record vendors such as Epic, which are adding AI features. Its strengths are breadth of products and General Catalyst's network of health system partners.
Commure at a glance
Commure is a Mountain View healthcare technology company incubated by General Catalyst in 2017 and merged with Athelas in 2023, led by CEO Tanay Tandon. It offers ambient AI, revenue cycle automation, patient engagement, remote monitoring and staff safety tools. It was reported in 2025 to be valued at about US$7 billion after a US$70 million round, and received US$200 million in growth financing from General Catalyst.
Timeline
- 2017: incubated by General Catalyst.
- 2019–2022: builds its platform and acquires healthcare technology companies.
- 2023: merges with Athelas; Tanay Tandon becomes CEO.
- 2024–2025: expands ambient AI and revenue cycle offerings.
- 2025: reported US$7 billion valuation; US$200 million growth financing.
Why healthcare admin is ripe for AI
US healthcare spends heavily on administration: coding visits, submitting claims, appealing denials, documenting care and scheduling. Doctors often spend hours a day on documentation, contributing to burnout. AI can listen to visits and write notes, suggest billing codes, predict claim denials and handle routine patient messages. These tasks are repetitive, rules-based and measurable, making them well suited to automation and easy to quantify in terms of time saved and revenue recovered.
General Catalyst's health strategy
General Catalyst has built an unusual healthcare strategy, incubating companies such as Commure and, in 2024, agreeing to buy a health system, Summa Health in Ohio, to show how technology can transform care delivery. Commure benefits from this ecosystem, gaining access to partners and customers that want to modernise operations.
Who uses Commure
Commure's customers include hospitals, health systems, physician groups and specialty practices, along with their clinicians, billing teams and staff.
Valuation context
A reported US$7 billion valuation places Commure among the most valuable healthcare AI companies, alongside ambient AI leaders. Our guide to healthcare AI startups compares related companies.
Risks
- Competition: EHR vendors and specialist AI companies target the same budgets.
- Integration: combining acquired products into one platform is hard.
- Investor concentration: heavy reliance on one venture firm.
- Regulation: billing automation faces compliance scrutiny.
Questions for health systems
- How well does it integrate with your EHR?
- What results has it delivered for similar organisations?
- How is pricing tied to outcomes or collections?
Ambient AI in the exam room
Ambient AI scribes have become one of the fastest-adopted AI tools in healthcare. With the patient's consent, the software listens to the conversation between clinician and patient, then produces a structured draft note, often including a summary, assessment, plan and suggested billing codes, which the clinician reviews and signs. Health systems report that clinicians spend less time typing after hours and can pay more attention to patients during visits. The main concerns are accuracy, privacy and whether time saved is used to see more patients rather than to reduce burnout. Because many vendors now offer similar capabilities, buyers increasingly compare price, integration with their electronic health record and how well the notes fit each specialty.
Revenue cycle as a service
Revenue cycle management covers everything from verifying insurance to coding visits, submitting claims, appealing denials and collecting payments. Many medical groups outsource it. Commure combines AI with human teams to run this process for clients, often charging a share of collections, which aligns its income with how much the client is paid.
Latest developments (October 2026)
We could not confirm any new Commure funding announcement in 2026 from reliable sources; some low-quality websites repeated an unverified claim of a new round, which we do not rely on. The reported 2025 valuation of about US$7 billion remains our latest sourced figure. Commure continues to sell AI tools for clinical documentation, revenue cycle management and operations to health systems, competing with Abridge and Ambience Healthcare in ambient documentation.
What to watch
Watch ambient AI adoption, revenue cycle growth, further acquisitions and new funding.
Takeaways
Health systems can automate documentation and billing. Founders can see how incubation and mergers can build a platform. Investors should note that its valuation is reported.
Sources
Every figure on this page comes from the public sources below. Where sources disagreed, we used the company's own announcement or a primary news report. Private-company data changes; check the date beside each figure.
Frequently asked questions
What does Commure do?
Commure is a healthcare / ai for health system operations company headquartered in Mountain View, California, United States. It was founded in 2017.
What is Commure's valuation?
Commure was valued at About US$7 billion (reported) as of 2025, according to MobiHealthNews. Private company valuations are set at funding rounds or share sales and can change significantly between them.
How much revenue does Commure make?
Commure is a private company and has not publicly disclosed its revenue. Figures on third-party sites are usually modelled estimates rather than numbers reported by the company.
What was Commure's latest funding round?
The most recent financing we have verified is a equity round in 2025: US$70M, at a valuation of About US$7B post-money (reported). Source: MobiHealthNews.
Who are Commure's investors?
Investors named in public announcements include General Catalyst, Sequoia Capital and Morgan Stanley.
Who founded Commure?
Commure was founded in 2017 by Incubated by General Catalyst; Tanay Tandon (CEO).
Is Commure a public company?
No. Commure is a private company (private, venture backed), so its shares are not traded on a stock exchange and it isn't required to publish its financial results.
Where is Commure headquartered?
Commure is headquartered in Mountain View, California, United States.